Editas Medicine Inc

Editas Medicine Inc

EDIT

Get informed when a big investor buys or sells

+ Follow
Market Cap$252.58M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Editas Medicine IncEditas Medicine Inc-2.1--2472%-14
$4.00

Target Price by Analysts

45.5% upsideEditas Medicine Target Price DetailsTarget Price
$-1.25

Current Fair Value

145.3% downside

Overvalued by 145.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$252.58 Million
Enterprise Value$190.74 Million
Dividend Yield$- (-)
Earnings per Share$-1.8
Beta2.1
Outstanding Shares97,879,343

Return

Return on Equity-2471.73%ROE
Return on Assets-72.96%
Return on Invested Capital67.43%

Valuation & Multiples

P/E Ratio-2.1P/E Ratio
PEG3.13PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue5.32
Enterprise Value to EBIT2.58
Enterprise Value to Net Income-2
Total Debt to Enterprise0.32
Debt to Equity14.02Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 5, 2026
EPS Estimate
$-0.30
Average shareholder expectation
Revenue Estimate
$2.85 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
$-0.27
Average shareholder expectation
Revenue Estimate
$2.85 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 68.82%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.80%▼ 57.65%
Total Invested$2.56M▼ 98.02%
Investors Holding49▼ 165.00%

ESG Score

No data

About Editas Medicine Inc

CEO: Cynthia Collins